| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2010-02-272005 |
| P953 | full work available at URL | http://www.bloodjournal.org/cgi/content/abstract/116/22/4512 |
| https://europepmc.org/articles/pmc2996113 | ||
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20693431/?tool=EBI | ||
| https://doi.org/10.1182/blood-2010-02-272005 | ||
| https://europepmc.org/articles/PMC2996113 | ||
| http://ashpublications.org/blood/article-pdf/116/22/4512/1496552/zh804810004512.pdf | ||
| P932 | PMC publication ID | 2996113 |
| P698 | PubMed publication ID | 20693431 |
| P5875 | ResearchGate publication ID | 45538040 |
| P2093 | author name string | Peter M. Henson | |
| R. William Vandivier | |||
| Ruby Fernandez-Boyanapalli | |||
| Donna L. Bratton | |||
| David W. H. Riches | |||
| S. Courtney Frasch | |||
| P2860 | cites work | Advances in treatment for chronic granulomatous disease | Q45880406 |
| Molecular circuits of resolution: formation and actions of resolvins and protectins | Q46391207 | ||
| Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus | Q46774498 | ||
| Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. | Q46815296 | ||
| Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response | Q47976088 | ||
| PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. | Q54439080 | ||
| Apoptotic cells induce a phosphatidylserine-dependent homeostatic response from phagocytes. | Q54571000 | ||
| Leukotriene production and inactivation by normal, chronic granulomatous disease and myeloperoxidase-deficient neutrophils | Q70175878 | ||
| Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages | Q79287661 | ||
| Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals | Q80141341 | ||
| Chronic granulomatous disease | Q84018615 | ||
| ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages | Q24683025 | ||
| Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production | Q28114945 | ||
| Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation | Q28344659 | ||
| The p47phox mouse knock-out model of chronic granulomatous disease | Q28504676 | ||
| Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase | Q28587071 | ||
| Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
| Alternative activation of macrophages: an immunologic functional perspective | Q29614353 | ||
| Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance | Q29614354 | ||
| Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages | Q29616355 | ||
| Genetic, biochemical, and clinical features of chronic granulomatous disease. | Q30168989 | ||
| Complement-dependent clearance of apoptotic cells by human macrophages | Q30442812 | ||
| Clinical aspects of chronic granulomatous disease | Q31804597 | ||
| Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms | Q33304942 | ||
| Granulocyte apoptosis and its role in the resolution and control of lung inflammation | Q33771415 | ||
| Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease. | Q33868203 | ||
| A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo | Q33912964 | ||
| Phagocytosis and clearance of apoptotic cells is mediated by MER. | Q33946282 | ||
| The phosphatidylserine receptor: a crucial molecular switch? | Q34325344 | ||
| Stimulatory Effects of Peroxisome Proliferator-Activated Receptor-gamma on Fcgamma Receptor-Mediated Phagocytosis by Alveolar Macrophages | Q36417564 | ||
| PPARs and other nuclear receptors in inflammation | Q36507833 | ||
| Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease | Q36622217 | ||
| PPARs and molecular mechanisms of transrepression | Q36791361 | ||
| Clearance of apoptotic cells by phagocytes | Q36850155 | ||
| NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A | Q36981038 | ||
| Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4 | Q37116947 | ||
| Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate | Q37215898 | ||
| Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways | Q38316513 | ||
| Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease | Q39830520 | ||
| Phospholipid flip-flop and phospholipid scramblase 1 (PLSCR1) co-localize to uropod rafts in formylated Met-Leu-Phe-stimulated neutrophils | Q40591748 | ||
| Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. | Q41782419 | ||
| Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases | Q43612862 | ||
| Gene correction reduces cutaneous inflammation and granuloma formation in murine X-linked chronic granulomatous disease. | Q43900123 | ||
| PPARgamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13. | Q43974270 | ||
| Oxidant-mediated phosphatidylserine exposure and macrophage uptake of activated neutrophils: possible impairment in chronic granulomatous disease. | Q43982575 | ||
| IL-13 attenuates gastrointestinal candidiasis in normal and immunodeficient RAG-2(-/-) mice via peroxisome proliferator-activated receptor-gamma activation | Q44133828 | ||
| Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation | Q44164532 | ||
| Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). | Q44417195 | ||
| Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages | Q44620791 | ||
| The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency | Q45285892 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| chronic granulomatous disease | Q2165663 | ||
| P304 | page(s) | 4512-4522 | |
| P577 | publication date | 2010-08-06 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease | |
| P478 | volume | 116 |
| Q58726344 | 15d-PGJ-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice |
| Q39016299 | An Update on the Use of Immunomodulators in Primary Immunodeficiencies |
| Q36797270 | An efferocytosis-induced, IL-4-dependent macrophage-iNKT cell circuit suppresses sterile inflammation and is defective in murine CGD |
| Q26825935 | Apoptotic cell clearance: basic biology and therapeutic potential. |
| Q55385710 | Chronic Granulomatous Disease: Epidemiology, Pathophysiology, and Genetic Basis of Disease. |
| Q35098193 | Chronic granulomatous disease: overview and hematopoietic stem cell transplantation |
| Q35745685 | Corticosteroid therapy for liver abscess in chronic granulomatous disease |
| Q35131029 | Current concepts of hyperinflammation in chronic granulomatous disease |
| Q26864795 | Emerging roles for lysophosphatidylserine in resolution of inflammation |
| Q38042926 | Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation |
| Q28260398 | Ex vivo and in vitro effect of serum amyloid a in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophils |
| Q59361040 | Future of Care for Patients With Chronic Granulomatous Disease: Gene Therapy and Targeted Molecular Medicine |
| Q89266985 | Galectin-3 in M2 Macrophages Plays a Protective Role in Resolution of Neuropathology in Brain Parasitic Infection by Regulating Neutrophil Turnover |
| Q38046124 | Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis |
| Q33984427 | Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications |
| Q36269059 | Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment |
| Q41755070 | Interstitial lung disease with multiple microgranulomas in chronic granulomatous disease |
| Q38363796 | Macrophage defense mechanisms against intracellular bacteria. |
| Q53604237 | Mer signaling increases the abundance of the transcription factor LXR to promote the resolution of acute sterile inflammation. |
| Q35927561 | Modulation of macrophage efferocytosis in inflammation |
| Q30538643 | Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. |
| Q37441655 | Myeloid Cell Turnover and Clearance |
| Q54241856 | NADPH oxidase activation regulates apoptotic neutrophil clearance by murine macrophages. |
| Q36586166 | NADPH oxidase and Nrf2 regulate gastric aspiration-induced inflammation and acute lung injury. |
| Q36382191 | NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis. |
| Q33911333 | NOX2-dependent regulation of inflammation |
| Q35151051 | Neutrophil clearance: when the party is over, clean-up begins |
| Q28282760 | Neutrophils regulate tissue Neutrophilia in inflammation via the oxidant-modified lipid lysophosphatidylserine |
| Q34307982 | Obesity impairs apoptotic cell clearance in asthma |
| Q26771755 | PPARγ and the Innate Immune System Mediate the Resolution of Inflammation |
| Q28070173 | PPARγ in Bacterial Infections: A Friend or Foe? |
| Q37089046 | Phagocyte respiratory burst activates macrophage erythropoietin signalling to promote acute inflammation resolution. |
| Q35090974 | Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease. |
| Q90383809 | Recent advances in chronic granulomatous disease |
| Q52733597 | Role of gp91phox in hepatic macrophage programming and alcoholic liver disease. |
| Q28304843 | Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity |
| Q36509966 | Systemic analysis of PPARγ in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity |
| Q34680660 | The Role of Efferocytosis in Atherosclerosis |
| Q38644234 | The role of mitochondrial ROS in antibacterial immunity. |
| Q36432359 | VIP treatment prevents embryo resorption by modulating efferocytosis and activation profile of maternal macrophages in the CBAxDBA resorption prone model |
Search more.